[Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine].

J Cooreman, G Burghard, J Grosset
{"title":"[Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine].","authors":"J Cooreman,&nbsp;G Burghard,&nbsp;J Grosset","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this work was to study drug resistance of M. tuberculosis to Streptomycin (SM), Isoniazid (INH), Ethambutol (EMB) and Rifampicin (RMP) in the department of the Bas-Rhin from 1971 to 1978. On 2,995 original culture plates which were positive, 1,561 antibiograms were performed at the C.E.R.P. The proportion of those tested has increased over the years from 27.8% in 1971 to 80.6% in 1978 because of the increasing number of laboratories participating in the study. The research is based on 1,511 cultures of M. tuberculosis and the population was split into two groups: 1,386 untreated subjects or treated for less than 15 days (primary resistance) and 125 subjects who had already been treated (acquired resistance). Over all the years, primary resistance to at least one drug was 6.9%. Primary resistance to SM was 3.0%, to INH 2.2% and to both 1.4% (the levels of primary resistance to EMB and RMP were practically nil). Acquired resistance to at least one of these antibiotics was 16.0% with the same order as for primary resistance: resistance to SM alone = 7.2%, to INH alone 4.0% and both together 2.4%. The proportions were greater than for primary resistance but concerned fewer subjects as only 8% of the population had been previously treated. There were no cases of primary or acquired resistance to Rifampicin alone.</p>","PeriodicalId":76480,"journal":{"name":"Revue francaise des maladies respiratoires","volume":"11 5","pages":"699-704"},"PeriodicalIF":0.0000,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue francaise des maladies respiratoires","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this work was to study drug resistance of M. tuberculosis to Streptomycin (SM), Isoniazid (INH), Ethambutol (EMB) and Rifampicin (RMP) in the department of the Bas-Rhin from 1971 to 1978. On 2,995 original culture plates which were positive, 1,561 antibiograms were performed at the C.E.R.P. The proportion of those tested has increased over the years from 27.8% in 1971 to 80.6% in 1978 because of the increasing number of laboratories participating in the study. The research is based on 1,511 cultures of M. tuberculosis and the population was split into two groups: 1,386 untreated subjects or treated for less than 15 days (primary resistance) and 125 subjects who had already been treated (acquired resistance). Over all the years, primary resistance to at least one drug was 6.9%. Primary resistance to SM was 3.0%, to INH 2.2% and to both 1.4% (the levels of primary resistance to EMB and RMP were practically nil). Acquired resistance to at least one of these antibiotics was 16.0% with the same order as for primary resistance: resistance to SM alone = 7.2%, to INH alone 4.0% and both together 2.4%. The proportions were greater than for primary resistance but concerned fewer subjects as only 8% of the population had been previously treated. There were no cases of primary or acquired resistance to Rifampicin alone.

[下莱茵省科氏杆菌对抗菌剂的耐药性]。
本文对1971 ~ 1978年下鼻内科结核分枝杆菌对链霉素(SM)、异烟肼(INH)、乙胺丁醇(EMB)和利福平(RMP)的耐药性进行了研究。在2,995个阳性的原始培养板上,在C.E.R.P.进行了1,561个抗生素检测。由于参与研究的实验室越来越多,这些检测的比例从1971年的27.8%增加到1978年的80.6%。该研究基于1511例结核分枝杆菌培养,人群被分成两组:1386例未经治疗或治疗少于15天(原发性耐药)和125例已接受治疗(获得性耐药)的受试者。多年来,对至少一种药物的原发性耐药率为6.9%。对SM的原发性耐药率为3.0%,对INH的原发性耐药率为2.2%,对两者的原发性耐药率均为1.4%(对EMB和RMP的原发性耐药率几乎为零)。对这些抗生素中至少一种的获得性耐药率为16.0%,与原发性耐药顺序相同:单独对SM耐药= 7.2%,单独对INH耐药4.0%,两者合并耐药2.4%。这一比例高于原发性耐药,但涉及的受试者较少,因为只有8%的人口以前接受过治疗。没有单独对利福平产生原发或获得性耐药的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信